skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Your current opinion on CARA please. It continues to under perform. Would you recommend selling it and buying something else in the Consumer space? Thanks.
Read Answer Asked by David on May 23, 2017
Q: Hi 5iResearch Team,

I have a full position on CVS for just over a year the stock has not been doing great over this period of time. I understand from a piece on BNN that Amazon is looking at getting into the pharmacy business.

If indeed that comes to past, I imagine it would impact negatively on pharmacies such as CVS, Walgreen, etc. So I am contemplating of liquidating my position on CVS. Your comments and thoughts on this would be appreciated.
Thanks,
Harry
Read Answer Asked by Harry on May 23, 2017
Q: Hi,

According to Morningstar, ECI's dividend payout ratio is 184 %. If I am not mistaken, such a high ratio is often a sign that the dividend is unsustainable. According to your latest report and answers, ECI seems to be in good shape financially and well set up for future growth, even after the recent earnings miss. Could you please explain when and why such a high ratio should or should not be a source of worry?

Thank you very much!
Read Answer Asked by Pierre-Charles on May 23, 2017
Q: Just a comment and clarification on Stevens Qs: I am surprised the 6.25% minimum ECN preferred share financing is still open as it's only $100M. Does this reflect badly on the issue? I thought a 6.25% guaranteed minimum was a good buy even if rates eventually rise.
Thanks.

--- The issue was closed the same day at TD and the issue has been completed yesterday as per mail from TDW.

Issue Completed - ECN Capital Corp. 6.25% Cumulative Rate Reset Preferred Shares, Series C

I also see that they have taken the money from my account for shares allocated.
Read Answer Asked by Mayur on May 19, 2017
Q: Can you elaborate on the restatement of its financials as to timing and substance. If on April 26, why the recent drop? Have to say these medical roll up companies are not worth the ride, there always seems to be something. No desire to hold this one as it rides down but can you provide an assessment of value of the stock today and whether sale at this juncture is not advisable. I assume this may take a lot of time to change the momentum of the stock. Thx
Read Answer Asked by Patrick on May 19, 2017
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!